Neuropathic Pain Scale (NPS)

ورودی‌های بالینی بیمار

حداقل ۰ — حداکثر ۱۰ • واحد: points (0 = no pain, 10 = most pain imaginable)

حداقل ۰ — حداکثر ۱۰ • واحد: points (0 = no pain, 10 = most pain imaginable)

حداقل ۰ — حداکثر ۱۰ • واحد: points (0 = no pain, 10 = most pain imaginable)

حداقل ۰ — حداکثر ۱۰ • واحد: points (0 = no pain, 10 = most pain imaginable)

حداقل ۰ — حداکثر ۱۰ • واحد: points (0 = no pain, 10 = most pain imaginable)

حداقل ۰ — حداکثر ۱۰ • واحد: points (0 = no pain, 10 = most pain imaginable)

حداقل ۰ — حداکثر ۱۰ • واحد: points (0 = no pain, 10 = most pain imaginable)

حداقل ۰ — حداکثر ۱۰ • واحد: points (0 = no pain, 10 = most pain imaginable)

حداقل ۰ — حداکثر ۱۰ • واحد: points (0 = no pain, 10 = most pain imaginable)

حداقل ۰ — حداکثر ۱۰ • واحد: points (0 = no pain, 10 = most pain imaginable)

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
total score
—points
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Mild0–20
  • Moderate21–40
  • Severe41–60
  • Very Severe61–100
Direct Clinical Answer

The Neuropathic Pain Scale (NPS) calculates quantifying neurological deficit severity, stroke volume, and reperfusion therapy eligibility. Key inputs include intensity. Scores guide initiating intravenous thrombolysis, activating endovascular thrombectomy pathways, or secondary prevention protocols. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Quantifies severity of neuropathic pain using 10 specific pain quality dimensions. Only for patients already diagnosed with neuropathic pain.

Clinical Indication

The Neuropathic Pain Scale (NPS) is indicated for bedside clinical practice to support Quantifies severity of neuropathic pain using 10 specific pain quality dimensions. Only for patients already diagnosed with neuropathic pain.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with acute neurological deficits, acute ischemic stroke, intracranial hemorrhage, seizures, or altered mental status. Clinical application is indicated across Comprehensive stroke centers, acute neurovascular units, neuro-ICU, and emergency neurology services.

Limitations & Contraindications

Stroke mimics including severe hypoglycemia, Todd postictal paresis, and hemiplegic migraine must be ruled out prior to intravenous thrombolysis.

Clinical Pearls & Action Plan

Time is brain; rapid determination of Last Known Well time and baseline functional status dictates reperfusion eligibility. Guideline pearl: Useful for assessing pain severity and monitoring treatment response.

Formula & Variables:

Total Score = Sum of all 10 item scores (each scored 0-10)

Input Parameters

NameTypeRequiredDescription
intensityintegerYesHow intense is the pain?(points (0 = no pain, 10 = most pain imaginable))
sharpintegerYesHow sharp is the pain? ('Like a knife')(points (0 = no pain, 10 = most pain imaginable))
hotintegerYesHow hot is the pain? ('On fire')(points (0 = no pain, 10 = most pain imaginable))
dullintegerYesHow dull is the pain?(points (0 = no pain, 10 = most pain imaginable))
coldintegerYesHow cold is the pain? ('Freezing')(points (0 = no pain, 10 = most pain imaginable))
sensitiveintegerYesHow sensitive is the skin to light touch? ('Raw skin')(points (0 = no pain, 10 = most pain imaginable))
itchyintegerYesHow itchy is the pain?(points (0 = no pain, 10 = most pain imaginable))
unpleasantintegerYesHow unpleasant is the pain? ('Intolerable')(points (0 = no pain, 10 = most pain imaginable))
deep_painintegerYesIf the pain is deep, how intense is the deep pain?(points (0 = no pain, 10 = most pain imaginable))
surface_painintegerYesIf the pain is on the surface, how intense is the surface pain?(points (0 = no pain, 10 = most pain imaginable))

Score Interpretation & Guidance

RangeStageDescription
0–20MildMild neuropathic pain
21–40ModerateModerate neuropathic pain
41–60SevereSevere neuropathic pain
61–100Very SevereVery severe neuropathic pain

Evidence-Based References (EBM)

  • Galer BS, Jensen MP. Development and preliminary validation of a pain measure specific to neuropathic pain: the Neuropathic Pain Scale. Neurology. 1997 Feb;48(2):332-8. doi: 10.1212/wnl.48.2.332.DOI: 10.1212/wnl.48.2.332

Related calculators